A Randomized Trial of Angiotensin Receptor bLocker,Fimasartan, in Aortic Stenosis (ALFA Trial)
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.
Also called NCT01589380
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 100 participants
- Sponsor
- Registry
-
NCT01589380
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- South Korea
- Registry status
- Unknown status
Technical summary
Registry record NCT01589380. Randomized; quadruple masking; primary purpose treatment. Start 2012-04 (registry gives no type); primary completion 2013-05 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Randomized Trial of Angiotensin Receptor bLocker,Fimasartan, in Aortic Stenosis (ALFA Trial)
- Acronym
- ALFA
- Condition
- Critical Stenosis of Aortic Valve
- Intervention (Drug)
- Fimasartan
- Intervention (Drug)
- Placebo
- Lead sponsor
- Seoul National University Hospital
- Collaborator
- Boryung Pharmaceutical Co., Ltd
- Collaborator
- Seoul National University Bundang Hospital
- Collaborator
- Severance Hospital
- Collaborator
- Korea University Anam Hospital
- Collaborator
- Korea University Guro Hospital
- Collaborator
- Chonnam National University Hospital
- Collaborator
- Samsung Medical Center
Record details
- Record id
cardio:ct-nct01589380- Content hash
4823df27f502bead399d9a70529326e2c34021192b6c144c9fd6dc72ed0be747